Skip to content

Lifestyle Modification for Weight Loss in Schizophrenia

Lifestyle Modification for Weight Loss in Schizophrenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00990925
Enrollment
149
Registered
2009-10-07
Start date
2009-10-31
Completion date
2012-02-29
Last updated
2015-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Schizoaffective Disorder, Schizophrenia

Keywords

Obesity, Schizophrenia, Schizoaffective disorder, weight loss

Brief summary

The purpose of this study is to find out how effective lifestyle modification group therapy is on reducing body weight when compared to usual care in individuals with schizophrenia and/or schizoaffective disorder.

Interventions

BEHAVIORALNutritional Lifestyle Modification Group

Manualized group treatment to educate about basic nutritional concepts to help improve eating choices with the goal of losing weight.

OTHERUsual Care

Care as usual

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects will be between 18 and 65 years of age. 2. Have a BMI of 28 or greater. 3. Meet DSM-IV criteria for schizophrenia or schizoaffective disorder. 4. Be on a stable dose of antipsychotic medication for at least one month, with positive symptoms stability as judged by the clinical team and investigator.

Exclusion criteria

1. A history of dementia or mental retardation. 2. Not capable of giving informed consent for participation in this study. 3. Ongoing pregnancy. 4. Living in a structured environment where the meals are provided as part of the program, e.g., a group home, nursing home, etc.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is change in body weight from baseline.16 weeks, 6 month follow-up

Secondary

MeasureTime frame
Change in lab values from baseline (fasting serum glucose, glycosylated hemoglobin, insulin, LDL cholesterol, triglyceride levels)16 weeks, 6 month follow-up
Change in questionnaires and assessments (Q-LES-Q, QLS, PANSS, Food craving scales, Food frequency scales, Food preference scales)16 weeks, 6 month follow-up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026